We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

TDF VS LAM + ADV in LAM + ADV Treated LAM-resistant CHB Patients With Undetectable Hepatitis B Virus DNA

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01732367
Recruitment Status : Completed
First Posted : November 22, 2012
Last Update Posted : October 28, 2016
Kyungpook National University
Daegu Catholic University Medical Center
DongGuk University
Pusan National University Hospital
Yeungnam University Hospital
Information provided by (Responsible Party):
Jang Byoung Kuk, Keimyung University Dongsan Medical Center